Noticias de Resmed Cdi

Últimas noticias

Titulares en el idioma original de la fuente.

• 
  ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings? (se abre en una pestaña nueva)

  StockStory · 5 oct 2026

• 
  Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026 (se abre en una pestaña nueva)

  GlobeNewswire · 1 oct 2026

• 
  This Stock Could Be the Big Winner Out of Oura’s IPO (se abre en una pestaña nueva)

  Barrons.com · 28 sept 2026

• 
  Is ResMed A Better Way Than Stryker To Own Medical Device Growth? (se abre en una pestaña nueva)

  Trefis · 28 sept 2026

• 
  ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand (se abre en una pestaña nueva)

  MarketBeat · 21 sept 2026

• 
  ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures (se abre en una pestaña nueva)

  Insider Monkey · 19 sept 2026

• 
  Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like. (se abre en una pestaña nueva)

  Barrons.com · 15 sept 2026

• 
  This Analyst Just Upgraded ResMed Stock. Here's Why. (se abre en una pestaña nueva)

  Barchart · 15 sept 2026

• 
  Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)? (se abre en una pestaña nueva)

  Simply Wall St. · 15 sept 2026

• ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says (se abre en una pestaña nueva)

  MT Newswires · 15 sept 2026

• Is This the Right Time to Retain Resmed Stock in Your Portfolio? (se abre en una pestaña nueva)

  15 sept 2026

• Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls (se abre en una pestaña nueva)

  15 sept 2026

• Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More (se abre en una pestaña nueva)

  15 sept 2026

• Patient Monitoring Stocks Q2 Teardown: ResMed (NYSE:RMD) Vs The Rest (se abre en una pestaña nueva)

  14 sept 2026

• ResMed Stock: Is RMD Underperforming the Healthcare Sector? (se abre en una pestaña nueva)

  14 sept 2026

• Frazier Healthcare Partners Completes Acquisition of MatrixCare, Appoints Jonathan Lujan as Chief Executive Officer (se abre en una pestaña nueva)

  1 sept 2026

• Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference (se abre en una pestaña nueva)

  27 ago 2026

• 
  Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference (se abre en una pestaña nueva)

  GlobeNewswire · 19 may 2026

• 
  2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off (se abre en una pestaña nueva)

  StockStory · 2 oct 2026

• 2 Profitable Stocks Worth Investigating and 1 We Turn Down (se abre en una pestaña nueva)

  1 sept 2026

• 2 S&P 500 Stocks with Promising Prospects and 1 We Ignore (se abre en una pestaña nueva)

  27 ago 2026